期刊文献+

新疆哈萨克族食管鳞癌中TGF-β1、p-Smad2/3的表达及意义 被引量:9

Expression and significance of TGF-β1 and p-Smad 2/3 in XinJiang Kazakh esophageal squamous cell carcinoma
下载PDF
导出
摘要 目的探讨转化生长因子β1(transforming growth factor-β1,TGF-β1)、p-Smad 2/3蛋白在新疆哈萨克族食管鳞癌组织和癌旁正常黏膜组织中的表达及意义。方法选取96例食管鳞癌石蜡组织及46例癌旁石蜡组织制成组织芯片,采用免疫组化EnVision两步法检测TGF-β1、p-Smad 2/3的表达。结果 TGF-β1和p-Smad 2/3蛋白在食管鳞癌组织中阳性率分别为89.6%(86/96)、80.2%(77/96),与癌旁组织阳性率47.8%(22/46)、50.0%(23/46)相比,差异均有统计学意义(P<0.001),与患者性别、年龄、肿瘤分化程度、有无淋巴结转移及临床分期无相关性(P>0.05);食管鳞癌组织中TGF-β1、p-Smad 2/3的表达呈正相关,差异均有统计学意义(r=0.344,P<0.05)。结论 TGF-β1及p-Smad 2/3可能在新疆哈萨克族食管鳞癌的发生中起重要作用。 Purpose To investigate the expression and significance of TGF-β1 and p-Smad 2/3 protein in Kazak' s esophageal squa- mous cell carcinoma. Methods The expression of TGF-β1 and p-Smad 2/3 were examined by immunohistochemistry using tissue mi- croarray in ninety-six formalin-fixed, paraffin-embedded cases of esophageal squamous cell carcinoma and forty-six non-cancerous adja- cent tissue. Results The positive expression rates of TGF-β1 and p-Smad 2/3 in the esophageal squamous cell carcinoma tissues and non-cancerous adjacent tissuein cases was 89.6% (86/96) , 80. 2% (77/96), 47.8% (22/46), 50. 0% (23/46) respectively. There were significantly different (P 〈 0. 001 ). TGF-β1 and p-Smad 2/3 expression was not correlated with clinicopathologieal charac- teristics (P 〉 0. 05 ). In esophageal squamous cell carcinoma, the expression of TGF-β1 had a positive correlation with p-Smad 2/3 ( r = 0. 344, P 〈 0. 05 ). Conclusions TGF-β1 and p-Smad 2/3 may play an important role in the XinJiang Kazakh esophageal squa- mous cell carcinoma.
出处 《临床与实验病理学杂志》 CAS CSCD 北大核心 2013年第1期6-8,13,共4页 Chinese Journal of Clinical and Experimental Pathology
基金 国家自然科学基金(81160018) 人社部留学人员科技活动择优资助项目(2011LX004) 863重大项目课题(2012AA02A503) "十一五"国家科技支撑计划项目(2009BAI82B03) 国际科技合作与交流专项(2010DFB34100)
关键词 食管肿瘤 鳞癌 TGF-Β1 p-Smad 2 3 组织芯片 esophageal neoplasms squamous cell carcinoma TGF-β1 p-Smad 2/5 tissue microarray
  • 相关文献

参考文献4

二级参考文献21

  • 1许良中,杨文涛.免疫组织化学反应结果的判断标准[J].中国癌症杂志,1996,6(4):229-231. 被引量:1368
  • 2李锋,常彬,李新霞,庞丽娟,陆红芬,王坚,孙孟红,施达仁.石蜡包埋尤文瘤/外周原始神经外胚瘤中EWS-FLI1融合基因的表达[J].中华病理学杂志,2004,33(4):328-331. 被引量:9
  • 3王柏春,王胜发,毕宏远,樊占威,袁伟,禹亮,傅松滨.人食管癌中TGF-β受体Ⅰ和Ⅱ表达的临床分析[J].基础医学与临床,2007,27(7):822-823. 被引量:1
  • 4Derynck R, Zhang YE. Smad - dependent and Smad - independent pathways in TGF - beta family signalling [ J ]. Nature, 2003, 425 (6958) :577 - 584.
  • 5Munoz NM, Upton M, Rojas A, et al. Transforming growth factor beta receptor type II inactivation induces the malignant transformation of intestinal neoplasms initiated by Apc mutation [ J ]. Cancer Res, 2006,66 (20) :9837 -9844.
  • 6Zhao H, Shiina H, Greene KL, et al. CpG methylation at promoter site - 140 inactivates TGFbeta2 receptor gene in prostate cancer[ J]. Cancer, 2005,104( 1 ) :44 -52.
  • 7Fukai Y, Fukuchi M, Masuda N, et al. Reduced expression of transforming growth factor - beta receptors is an unfavorable prognostic factor in human esophageal squarnous cell carcinoma[ J]. Int J Cancer,2003,104 (2) :161 -166.
  • 8Xuan Y H,lin Z H.Expression of Indian Hedgehog signaling molecules in breast cancer[J].J Cancer Res Clin Oncol,2009,135(2):235-40.
  • 9Ray D,Tero Y,Nimbalkar D,et al.Transforming growth factorβ facilitates β-TrCP-mediated degradation of Cdc25A in a Smad3-dependent manner[J].Mol Cell Biol,2005,25(8):3338-47.
  • 10秦江梅,王秀梅,陈波,杨磊,李锋,何玲,廖佩花.新疆哈萨克族食管癌与叶酸摄入水平、亚甲基四氢叶酸还原酶基因多态关系的研究[J].中华流行病学杂志,2008,29(1):30-33. 被引量:13

共引文献28

同被引文献87

  • 1张晓菊,田拥军,丁静民,辛建保,陶晓南,白明.TGF-β1上调CD4^+CD25^+调节性T细胞FOXP3的表达[J].华中科技大学学报(医学版),2006,35(6):709-711. 被引量:5
  • 2牛坚,陈澍周,钱海鑫.TGF-β1和MMP-2在胆囊癌中表达及临床意义[J].肿瘤防治杂志,2005,12(9):686-689. 被引量:3
  • 3王先升,陈建,周涛,高彦.TGF-β_1在胃癌中的表达及意义[J].山东医药,2006,46(16):49-50. 被引量:4
  • 4张学彦,刘铁夫,于旸,崔希威.p15^(INK4B)基因转染联合TGF-β_1对人食管鳞癌的抑制作用[J].中国肿瘤临床,2006,33(20):1165-1168. 被引量:1
  • 5吴鹏,田媛,桂伶俐,陈刚,卢运萍,周剑锋,马丁.RNA干扰技术抑制smad4基因表达对宫颈癌细胞增殖的影响[J].肿瘤,2007,27(3):167-171. 被引量:3
  • 6Ying Huang,Wenfeng Fang,Yulei Wang,et al. Transforming growth factor-β1 induces glutathione peroxidase-1 and protects from H2O2- induced cell death in colon cancer cells via the Smad2/ERK1/2/HIF- 1 α pathway[J]. International Journal of Molecular Medicine,2012,29 (5) : 906-912.
  • 7Bao Y ,Jiang L,Shi Y. Increased expression of phosphorylated Smad2 and Smad3 in the hippocampus of streptozotocin-induced diabetic rats[J]. Experimental and clinical endocrinology and diabetes, 2010,118 ( 1 ) : 47-50.
  • 8Amar M,Singh David,Reynolds Timothy,et al. Signaling network erosstalk in human pluripotent eells:a Smad2/3-regulated switch that controls the balance between self-renewal and differentiation[J]. Cell stem cell, 2012,10(3) :312-326.
  • 9Ho Diana M ,Yeo Chang-Yeol,Whitman Malcohn. The role and regula- tion of GDF11 in Smad2 activation during tailbud formation in the Xenopus embryo[J]. Mechanisms of Development,2010,127 (9/12) :485- 495.
  • 10Adis T,Supranee K,Soodkate D,et ah Vitamin E ameliorates renal fibrosis by inhibition of TGF-beta/Smad2/3 signaling pathway in U- UO mice[J]. Journal of the Medical Association of Thailand,2011,94 (7):1-9.

引证文献9

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部